Elizabeth M. Haney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth M. Haney has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Christina Bougatsos
Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology
2 shared publicationsHeidi D. Nelson
From Oregon Health & Science University and Providence Cancer Center, Providence Health and Services Oregon, Portland, Oregon
2 shared publicationsLaurie Hoyt Huffman
Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology
2 shared publicationsM. Michael Bliziotes
Department of Medicine, Oregon Health & Science University, Portland, Oregon 97239
2 shared publicationsMichele Freeman
Oregon Evidence-based Practice Center, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239
2 shared publications- Robert D. Steiner
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health , Madison, WI
2 shared publications
Latest Publications
- Open Access
- 16 June 2015
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 162 (12) , 834-840
Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
Background: The diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical criteria, yet there has been no consensus regarding which set of criteria best identifies patients with the condition. The Institute of Medicine has recently proposed a new case definition and diagnostic algorithm. Purpose: To review methods to diagnose ME/CFS in adults and identify research gaps and needs for future research. Data Sources: MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014); clinical trial registries; and reference lists. Study Selection: English-language studies describing methods of diagnosis of ME/CFS and their accuracy. Data Extraction: Data on participants, study design, analysis, follow-up, and results were extracted and confirmed. Study quality was dual-rated by using prespecified criteria, and discrepancies were resolved through consensus. Data Synthesis: Forty-four studies met inclusion criteria. Eight case definitions have been used to define ME/CFS; a ninth, recently proposed by the Institute of Medicine, includes principal elements of previous definitions. Patients meeting criteria for ME represent a more symptomatic subset of the broader ME/CFS population. Scales rating self-reported symptoms differentiate patients with ME/CFS from healthy controls under study conditions but have not been evaluated in clinically undiagnosed patients to determine validity and generalizability. Limitations: Studies were heterogeneous and were limited by size, number, applicability, and methodological quality. Most methods were tested in highly selected patient populations. Conclusion: Nine sets of clinical criteria are available to define ME/CFS, yet none of the current diagnostic methods have been adequately tested to identify patients with ME/CFS when diagnostic uncertainty exists. More definitive studies in broader populations are needed to address these research gaps. Primary Funding Source: Agency for Healthcare Research and Quality. (PROSPERO: CRD42014009779)
- 16 June 2015
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 162 (12) , 834-840
Open AccessDiagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
Background: The diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical criteria, yet there has been no consensus regarding which set of criteria best identifies patients with the condition. The Institute of Medicine has recently proposed a new case definition and diagnostic algorithm. Purpose: To review methods to diagnose ME/CFS in adults and identify research gaps and needs for future research. Data Sources: MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014); clinical trial registries; and reference lists. Study Selection: English-language studies describing methods of diagnosis of ME/CFS and their accuracy. Data Extraction: Data on participants, study design, analysis, follow-up, and results were extracted and confirmed. Study quality was dual-rated by using prespecified criteria, and discrepancies were resolved through consensus. Data Synthesis: Forty-four studies met inclusion criteria. Eight case definitions have been used to define ME/CFS; a ninth, recently proposed by the Institute of Medicine, includes principal elements of previous definitions. Patients meeting criteria for ME represent a more symptomatic subset of the broader ME/CFS population. Scales rating self-reported symptoms differentiate patients with ME/CFS from healthy controls under study conditions but have not been evaluated in clinically undiagnosed patients to determine validity and generalizability. Limitations: Studies were heterogeneous and were limited by size, number, applicability, and methodological quality. Most methods were tested in highly selected patient populations. Conclusion: Nine sets of clinical criteria are available to define ME/CFS, yet none of the current diagnostic methods have been adequately tested to identify patients with ME/CFS when diagnostic uncertainty exists. More definitive studies in broader populations are needed to address these research gaps. Primary Funding Source: Agency for Healthcare Research and Quality. (PROSPERO: CRD42014009779)
- 1 July 2008
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 20 (4) , 423-428
Male osteoporosis: new insights in an understudied disease
Osteoporosis in men is increasingly recognized as an important health problem. New research contributes to our knowledge of gender differences in osteoporosis risk, diagnosis and management. We undertook this review to summarize recent developments in the field of male osteoporosis. The paper reviews recently published studies that reveal new insights into male osteoporosis. It addresses epidemiology, risk factors, use of clinical risk assessment tools, diagnosis and treatment. New data continue to suggest that men have higher mortality rates than women after hip fracture, and that men may experience fractures at higher bone mineral density values than women. Treatments for osteoporosis have been studied mostly in women, but trials including both men and women are now being conducted. Likewise, there are several newer cohorts with bone and fracture outcomes that include men and women. The Osteoporotic Fractures in Men (MrOS) study is the first United States-based cohort to include only men; this study is contributing importantly to our understanding of epidemiology and risk factors for osteoporosis in men. Men and their physicians should be aware of the risk for osteoporosis and the gender differences that exist within this disease. Further research is needed to continue to understand differences in pathophysiology, epidemiology and risk factors, and to promote appropriate therapies among men.
- 1 July 2008
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 20 (4) , 423-428
Male osteoporosis: new insights in an understudied disease
Osteoporosis in men is increasingly recognized as an important health problem. New research contributes to our knowledge of gender differences in osteoporosis risk, diagnosis and management. We undertook this review to summarize recent developments in the field of male osteoporosis. The paper reviews recently published studies that reveal new insights into male osteoporosis. It addresses epidemiology, risk factors, use of clinical risk assessment tools, diagnosis and treatment. New data continue to suggest that men have higher mortality rates than women after hip fracture, and that men may experience fractures at higher bone mineral density values than women. Treatments for osteoporosis have been studied mostly in women, but trials including both men and women are now being conducted. Likewise, there are several newer cohorts with bone and fracture outcomes that include men and women. The Osteoporotic Fractures in Men (MrOS) study is the first United States-based cohort to include only men; this study is contributing importantly to our understanding of epidemiology and risk factors for osteoporosis in men. Men and their physicians should be aware of the risk for osteoporosis and the gender differences that exist within this disease. Further research is needed to continue to understand differences in pathophysiology, epidemiology and risk factors, and to promote appropriate therapies among men.
- 10 January 2008
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 3 (1) , 1-3
Balancing bone health and mental health: a new clinical dilemma?
- 10 January 2008
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 3 (1) , 1-3
Balancing bone health and mental health: a new clinical dilemma?
- 1 July 2007
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 120 (1) , e189-e214
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
OBJECTIVE. This was a systematic evidence review for the US Preventive Services Task Force, intended to synthesize the published evidence regarding the effectiveness of selecting, testing, and managing children and adolescents with dyslipidemia in the course of routine primary care.METHODS. Literature searches were performed to identify published articles that addressed 10 key questions. The review focused on screening relevant to primary care of children without previously identified dyslipidemias, but included treatment trials of children with dyslipidemia because some drugs have only been tested in that population.RESULTS. Normal values for lipids for children and adolescents are defined according to population levels (percentiles). Age, gender, and racial differences and temporal trends may alter these statistical cut points. Approximately 40% to 55% of children with elevated total cholesterol and low-density lipoprotein levels will continue to have elevated lipid levels on follow-up. Current screening recommendations based on family history will fail to detect substantial numbers (30%–60%) of children with elevated lipid levels. Drug treatment for dyslipidemia in children has been studied and shown to be effective only for suspected or proven familial monogenic dyslipidemias. Intensive dietary counseling and follow-up can result in improvements in lipid levels, but these results have not been sustained after the cessation of the intervention. The few trials of exercise are of fair-to-poor quality and show little or no improvements in lipid levels for children without monogenic dyslipidemias. Although reported adverse effects were not serious, studies were generally small and not of sufficient duration to determine long-term effects of either short or extended use.CONCLUSIONS. Several key issues about screening and treatment of dyslipidemia in children and adolescents could not be addressed because of lack of studies, including effectiveness of screening on adult coronary heart disease or lipid outcomes, optimal ages and intervals for screening children, or effects of treatment of childhood lipid levels on adult coronary heart disease outcomes.
- 1 July 2007
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 120 (1) , e189-e214
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
OBJECTIVE. This was a systematic evidence review for the US Preventive Services Task Force, intended to synthesize the published evidence regarding the effectiveness of selecting, testing, and managing children and adolescents with dyslipidemia in the course of routine primary care.METHODS. Literature searches were performed to identify published articles that addressed 10 key questions. The review focused on screening relevant to primary care of children without previously identified dyslipidemias, but included treatment trials of children with dyslipidemia because some drugs have only been tested in that population.RESULTS. Normal values for lipids for children and adolescents are defined according to population levels (percentiles). Age, gender, and racial differences and temporal trends may alter these statistical cut points. Approximately 40% to 55% of children with elevated total cholesterol and low-density lipoprotein levels will continue to have elevated lipid levels on follow-up. Current screening recommendations based on family history will fail to detect substantial numbers (30%–60%) of children with elevated lipid levels. Drug treatment for dyslipidemia in children has been studied and shown to be effective only for suspected or proven familial monogenic dyslipidemias. Intensive dietary counseling and follow-up can result in improvements in lipid levels, but these results have not been sustained after the cessation of the intervention. The few trials of exercise are of fair-to-poor quality and show little or no improvements in lipid levels for children without monogenic dyslipidemias. Although reported adverse effects were not serious, studies were generally small and not of sufficient duration to determine long-term effects of either short or extended use.CONCLUSIONS. Several key issues about screening and treatment of dyslipidemia in children and adolescents could not be addressed because of lack of studies, including effectiveness of screening on adult coronary heart disease or lipid outcomes, optimal ages and intervals for screening children, or effects of treatment of childhood lipid levels on adult coronary heart disease outcomes.
- 1 July 2007
Screening for Lipid Disorders in Children and Adolescents
Dyslipidemias, disorders of lipid metabolism, are important risk factors for coronary heart disease (CHD). Identification of children with dyslipidemias could lead to interventions aimed at decreasing their risk of CHD as adults. To determine the strengths and limits of evidence about the effectiveness of selecting, testing, and managing children and adolescents with dyslipidemia in the course of routine primary care. Screening children and adolescents has the potential to identify three groups with dyslipidemia: those with 1) undiagnosed monogenic dyslipidemia, 2) undiagnosed secondary dyslipidemia, and 3) idiopathic dyslipidemia (polygenic, risk factor associated, or multifactorial). Key questions examined a chain of evidence about the accuracy and feasibility of screening children in various settings, tracking of lipid levels through childhood to adulthood, role of risk factors in selecting children for screening, effectiveness of interventions for children identified with dyslipidemia, and adverse effects of screening and interventions. Relevant studies were identified from multiple searches of MEDLINE, PsychInfo, the Cochrane database of systematic reviews and controlled clinical trials, and EMBASE (1966 to September 2005). Additional articles were obtained from recent systematic reviews, reference lists of pertinent studies, reviews, editorials, and websites, and by consulting experts. Eligible studies were applicable to U.S. clinical practice, available in English, and provided primary data relevant to key questions. Cohort studies were used for assessment of risk factors. Comparative and non-comparative prospective studies of screening for dyslipidemia in children provided information on the efficacy of these programs and the accuracy of screening with family history information. Randomized, non-randomized and non-comparative studies were used for assessment of risk factors. Only randomized controlled trials were considered for examining the effectiveness of interventions. Studies of children with previously diagnosed monogenic dyslipidemia were considered for the evaluation of treatment because those are the only children in whom some drugs have been tested. Data were extracted from each study and entered into evidence tables. Studies were summarized by descriptive methods and rated for quality using criteria developed by the U.S. Preventive Services Task Force (USPSTF). Normal values for lipids for children and adolescents are currently defined according to population levels (percentiles). More recent studies indicate age, sex, and racial differences and temporal trends that shift cut points. Tracking of lipid levels through childhood is strongest for TC and LDL. Approximately 40–55% of children with elevated total cholesterol (TC) and low-density lipoprotein (LDL) defined by percentile will continue to have elevated lipids on follow-up. Current screening recommendations based on family history will fail to detect substantial...
- 1 July 2007
Screening for Lipid Disorders in Children and Adolescents
Dyslipidemias, disorders of lipid metabolism, are important risk factors for coronary heart disease (CHD). Identification of children with dyslipidemias could lead to interventions aimed at decreasing their risk of CHD as adults. To determine the strengths and limits of evidence about the effectiveness of selecting, testing, and managing children and adolescents with dyslipidemia in the course of routine primary care. Screening children and adolescents has the potential to identify three groups with dyslipidemia: those with 1) undiagnosed monogenic dyslipidemia, 2) undiagnosed secondary dyslipidemia, and 3) idiopathic dyslipidemia (polygenic, risk factor associated, or multifactorial). Key questions examined a chain of evidence about the accuracy and feasibility of screening children in various settings, tracking of lipid levels through childhood to adulthood, role of risk factors in selecting children for screening, effectiveness of interventions for children identified with dyslipidemia, and adverse effects of screening and interventions. Relevant studies were identified from multiple searches of MEDLINE, PsychInfo, the Cochrane database of systematic reviews and controlled clinical trials, and EMBASE (1966 to September 2005). Additional articles were obtained from recent systematic reviews, reference lists of pertinent studies, reviews, editorials, and websites, and by consulting experts. Eligible studies were applicable to U.S. clinical practice, available in English, and provided primary data relevant to key questions. Cohort studies were used for assessment of risk factors. Comparative and non-comparative prospective studies of screening for dyslipidemia in children provided information on the efficacy of these programs and the accuracy of screening with family history information. Randomized, non-randomized and non-comparative studies were used for assessment of risk factors. Only randomized controlled trials were considered for examining the effectiveness of interventions. Studies of children with previously diagnosed monogenic dyslipidemia were considered for the evaluation of treatment because those are the only children in whom some drugs have been tested. Data were extracted from each study and entered into evidence tables. Studies were summarized by descriptive methods and rated for quality using criteria developed by the U.S. Preventive Services Task Force (USPSTF). Normal values for lipids for children and adolescents are currently defined according to population levels (percentiles). More recent studies indicate age, sex, and racial differences and temporal trends that shift cut points. Tracking of lipid levels through childhood is strongest for TC and LDL. Approximately 40–55% of children with elevated total cholesterol (TC) and low-density lipoprotein (LDL) defined by percentile will continue to have elevated lipids on follow-up. Current screening recommendations based on family history will fail to detect substantial...
- Open Access
- 25 June 2007
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (12) , 1246-1251
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Functional serotonin transporters have been identified in osteoblasts, osteocytes, and osteoclasts.1,2 The functionality of these bone serotonin transporters is suggested by studies in a mouse model of long-term selective serotonin reuptake inhibitor (SSRI) use. In this model, mice with genetic disruption of the serotonin transporter gene have lower bone mineral density (BMD) when compared with wild-type mice.3
- 25 June 2007
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (12) , 1246-1251
Open AccessAssociation of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Functional serotonin transporters have been identified in osteoblasts, osteocytes, and osteoclasts.1,2 The functionality of these bone serotonin transporters is suggested by studies in a mouse model of long-term selective serotonin reuptake inhibitor (SSRI) use. In this model, mice with genetic disruption of the serotonin transporter gene have lower bone mineral density (BMD) when compared with wild-type mice.3
- Open Access
- 6 July 2006
- Published by Springer Nature in BMC Medical Education
- Vol. 6 (1) , 35
Relationship between resident workload and self-perceived learning on inpatient medicine wards: a longitudinal study
Background: Despite recent residency workload and hour limitations, little research on the relationship between workload and learning has been done. We sought to define residents' perceptions of the optimal patient workload for learning, and to determine how certain variables contribute to those perceptions. Our hypothesis was that the relationship between perceived workload and learning has a maximum point (forming a parabolic curve): that either too many or too few patients results in sub-optimal learning. Methods: Residents on inpatient services at two academic teaching hospitals reported their team and individual patient censuses, and rated their perception of their learning; the patient acuity; case variety; and how challenged they felt. To estimate maximum learning scores, linear regression models with quadratic terms were fit on learning score. Results: Resident self-perceived learning correlated with higher acuity and greater heterogeneity of case variety. The equation of census versus learning score, adjusted for perception of acuity and case mix scores, showed a parabolic curve in some cases but not in others. Conclusion: These data suggest that perceived resident workload is complex, and impacted by additional variables including patient acuity and heterogeneity of case variety. Parabolic curves exist for interns with regard to overall census and for senior residents with regard to new admissions on long call days.
- 6 July 2006
- Published by Springer Nature in BMC Medical Education
- Vol. 6 (1) , 35
Open AccessRelationship between resident workload and self-perceived learning on inpatient medicine wards: a longitudinal study
Background: Despite recent residency workload and hour limitations, little research on the relationship between workload and learning has been done. We sought to define residents' perceptions of the optimal patient workload for learning, and to determine how certain variables contribute to those perceptions. Our hypothesis was that the relationship between perceived workload and learning has a maximum point (forming a parabolic curve): that either too many or too few patients results in sub-optimal learning. Methods: Residents on inpatient services at two academic teaching hospitals reported their team and individual patient censuses, and rated their perception of their learning; the patient acuity; case variety; and how challenged they felt. To estimate maximum learning scores, linear regression models with quadratic terms were fit on learning score. Results: Resident self-perceived learning correlated with higher acuity and greater heterogeneity of case variety. The equation of census versus learning score, adjusted for perception of acuity and case mix scores, showed a parabolic curve in some cases but not in others. Conclusion: These data suggest that perceived resident workload is complex, and impacted by additional variables including patient acuity and heterogeneity of case variety. Parabolic curves exist for interns with regard to overall census and for senior residents with regard to new admissions on long call days.
- 14 October 2004
- Published by Springer Nature in Calcified Tissue International
- Vol. 76 (1) , 11-16
Vitamin D Insufficiency in Internal Medicine Residents
Medical residents may be vulnerable to low vitamin D status because of long work hours and lack of sun exposure. We conducted a prospective cohort study to measure serum 25-hydroxyvitamin D concentrations among internal medicine residents, document seasonal variation in vitamin D status, and assess risk factors for inadequate vitamin D stores. Dietary intake of calcium and vitamin D, lifestyle characteristics, and serum concentrations of 25(OH)-vitamin D and intact parathyroid hormone (iPTH) were measured in 35 resident volunteers before and after the winter season. A total of 63–69% of medical residents consumed <400 IU/day of vitamin D; 61–67% consumed <1000 mg/day of calcium. Twenty-five (74%) had lower serum 25(OH)-vitamin D concentrations and 23 (68%) had higher serum iPTH in the spring than in the fall. Nine (26%) residents had serum concentrations of 25(OH)-vitamin D of <20 ng/mL in the fall; and sixteen (47%) in the spring. Seven residents (20%) had serum concentrations of 25(OH)-vitamin D of <20 ng/mL at both time-periods; Eighteen residents (51.4%) had 25(OH)-vitamin D levels of <20 ng/mL for at least one of the time-periods. Medical residents are at risk for hypovitaminosis D, particularly during the winter months and should be aware of the need to supplement their vitamin D stores. Insufficient vitamin D status and inadequate vitamin D intake may have long-term implications for bone health in these individuals. Increased educational efforts to promote healthy dietary and lifestyle choices that allow attainment and maintenance of skeletal health are appropriate in this population.
- 14 October 2004
- Published by Springer Nature in Calcified Tissue International
- Vol. 76 (1) , 11-16
Vitamin D Insufficiency in Internal Medicine Residents
Medical residents may be vulnerable to low vitamin D status because of long work hours and lack of sun exposure. We conducted a prospective cohort study to measure serum 25-hydroxyvitamin D concentrations among internal medicine residents, document seasonal variation in vitamin D status, and assess risk factors for inadequate vitamin D stores. Dietary intake of calcium and vitamin D, lifestyle characteristics, and serum concentrations of 25(OH)-vitamin D and intact parathyroid hormone (iPTH) were measured in 35 resident volunteers before and after the winter season. A total of 63–69% of medical residents consumed <400 IU/day of vitamin D; 61–67% consumed <1000 mg/day of calcium. Twenty-five (74%) had lower serum 25(OH)-vitamin D concentrations and 23 (68%) had higher serum iPTH in the spring than in the fall. Nine (26%) residents had serum concentrations of 25(OH)-vitamin D of <20 ng/mL in the fall; and sixteen (47%) in the spring. Seven residents (20%) had serum concentrations of 25(OH)-vitamin D of <20 ng/mL at both time-periods; Eighteen residents (51.4%) had 25(OH)-vitamin D levels of <20 ng/mL for at least one of the time-periods. Medical residents are at risk for hypovitaminosis D, particularly during the winter months and should be aware of the need to supplement their vitamin D stores. Insufficient vitamin D status and inadequate vitamin D intake may have long-term implications for bone health in these individuals. Increased educational efforts to promote healthy dietary and lifestyle choices that allow attainment and maintenance of skeletal health are appropriate in this population.